PHARMA DE COCK: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PHARMA DE COCK
Largest movements
- Receivables within one year +€47,484
up €47,484 (+46.2%), from €102,836 to €150,321
of which Other amounts receivable: +€59,102
- Stocks and contracts +€26,416
up €26,416 (+22.3%), from €118,401 to €144,817
- Tangible fixed assets -€14,817
down €14,817 (-6.0%), from €245,989 to €231,173
of which Plant, machinery and equipment: -€12,118
- Reserves +€56,674
up €56,674 (+75.3%), from €75,254 to €131,928
- Debts after one year -€38,220
down €38,220 (-28.9%), from €132,328 to €94,108
- Short-term financial debts +€25,000
up €25,000 (+25.0%), from €100,000 to €125,000
- Trade debts +€5,883
up €5,883 (+5.9%), from €100,230 to €106,113
- Gross operating margin -€21,016
down €21,016 (-9.3%), from €226,840 to €205,824
- Taxes +€8,550
up €8,550 (+141%), from €6,077 to €14,627
- Financial charges +€2,685
up €2,685 (+10.4%), from €25,904 to €28,589
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €531,534 | €587,807 | +€56,273 | +10.6% |
| Formation expenses | 20 | €1,828 | €1,250 | -€578 | -31.6% |
| Fixed assets | 21/28 | €245,989 | €231,173 | -€14,817 | -6.0% |
| Tangible fixed assets | 22/27 | €245,989 | €231,173 | -€14,817 | -6.0% |
| Plant, machinery and equipment | 23 | €117,506 | €105,387 | -€12,118 | -10.3% |
| Furniture and vehicles | 24 | €17,559 | €13,779 | -€3,780 | -21.5% |
| Other tangible fixed assets | 26 | €110,925 | €112,007 | +€1,081 | +1.0% |
| Current assets | 29/58 | €283,717 | €355,385 | +€71,668 | +25.3% |
| Stocks and contracts in progress | 3 | €118,401 | €144,817 | +€26,416 | +22.3% |
| Stocks | 30/36 | €118,401 | €144,817 | +€26,416 | +22.3% |
| Amounts receivable within one year | 40/41 | €102,836 | €150,321 | +€47,484 | +46.2% |
| Trade receivables | 40 | €77,933 | €66,315 | -€11,618 | -14.9% |
| Other amounts receivable | 41 | €24,903 | €84,005 | +€59,102 | +237% |
| Cash at bank and in hand | 54/58 | €60,583 | €58,357 | -€2,225 | -3.7% |
| Deferred charges and accrued income | 490/1 | €1,896 | €1,889 | -€7 | -0.4% |
| Total equity and liabilities | 10/49 | €531,534 | €587,807 | +€56,273 | +10.6% |
| Equity | 10/15 | €136,754 | €193,428 | +€56,674 | +41.4% |
| Contributions | 10/11 | €61,500 | €61,500 | = | 0.0% |
| Contributions outside capital | 11 | €61,500 | €61,500 | = | 0.0% |
| Other | 1109/19 | €61,500 | €61,500 | = | 0.0% |
| Reserves | 13 | €75,254 | €131,928 | +€56,674 | +75.3% |
| Distributable reserves | 133 | €75,254 | €131,928 | +€56,674 | +75.3% |
| Profit (loss) carried forward | 14 | €0 | - | = | |
| Amounts payable | 17/49 | €394,780 | €394,379 | -€401 | -0.1% |
| Amounts payable after more than one year | 17 | €132,328 | €94,108 | -€38,220 | -28.9% |
| Financial debts | 170/4 | €132,328 | €94,108 | -€38,220 | -28.9% |
| Amounts payable within one year | 42/48 | €260,945 | €298,305 | +€37,361 | +14.3% |
| Current portion of amounts payable after more than one year | 42 | €39,473 | €40,833 | +€1,360 | +3.4% |
| Financial debts | 43 | €100,000 | €125,000 | +€25,000 | +25.0% |
| Credit institutions | 430/8 | €100,000 | €125,000 | +€25,000 | +25.0% |
| Trade debts | 44 | €100,230 | €106,113 | +€5,883 | +5.9% |
| Suppliers | 440/4 | €100,230 | €106,113 | +€5,883 | +5.9% |
| Taxes, remuneration and social security | 45 | €20,655 | €24,143 | +€3,488 | +16.9% |
| Taxes | 450/3 | €6,903 | €14,627 | +€7,724 | +112% |
| Remuneration and social security | 454/9 | €13,752 | €9,516 | -€4,236 | -30.8% |
| Other amounts payable | 47/48 | €587 | €2,216 | +€1,629 | +278% |
| Accrued charges and deferred income | 492/3 | €1,508 | €1,966 | +€458 | +30.4% |
| Remuneration, social security and pensions | 62 | €77,099 | €74,874 | -€2,225 | -2.9% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €29,749 | €31,060 | +€1,311 | +4.4% |
| Other operating charges | 640/8 | €765 | €814 | +€48 | +6.3% |
| Gross operating margin | 9900 | €226,840 | €205,824 | -€21,016 | -9.3% |
| Operating profit (loss) | 9901 | €119,226 | €99,076 | -€20,150 | -16.9% |
| Financial income | 75/76B | €334 | €814 | +€480 | +144% |
| Recurring financial income | 75 | €334 | €814 | +€480 | +144% |
| Financial charges | 65/66B | €25,904 | €28,589 | +€2,685 | +10.4% |
| Recurring financial charges | 65 | €25,904 | €28,589 | +€2,685 | +10.4% |
| Profit (loss) for the period before taxes | 9903 | €93,656 | €71,301 | -€22,355 | -23.9% |
| Income taxes | 67/77 | €6,077 | €14,627 | +€8,550 | +141% |
| Profit (loss) for the period | 9904 | €87,579 | €56,674 | -€30,905 | -35.3% |
| Profit (loss) for the period to be appropriated | 9905 | €87,579 | €56,674 | -€30,905 | -35.3% |
Source: filed annual accounts (NBB), financial years ended 30 September 2024 and 30 September 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 25 October 2026 via checked.be.